Short-chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory

Maria Inmaculada Dominguez-Mozo1, Daniel López-Mecández2, Luisa María Villar3

  • 1Grupo de Investigación de Factores ambientales en enfermedades degenerativas, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Red de Enfermedades Inflamatorias (REI), Red Española de Esclerosis Múltiple, Madrid, Spain.

Abstract

Insights

Short-chain fatty acids (SCFAs) like propionate (PA) and butyrate (BA) are altered in multiple sclerosis (MS) patients. Lower SCFA ratios correlate with increased disability and neurodegeneration markers in MS.

Area of Science:

  • Neuroimmunology
  • Microbiome research
  • Metabolomics

Background:

  • Alterations in gut microbiota composition are observed in multiple sclerosis (MS) patients compared to healthy controls (HC).
  • Microorganism-derived metabolites, such as short-chain fatty acids (SCFAs), are implicated in MS pathogenesis.
  • Understanding SCFA associations with disease parameters is crucial for MS research.

Purpose of the Study:

  • To investigate the association between plasma SCFA levels and clinical/radiological parameters in MS.
  • To explore the relationship between SCFAs and immune system inflammatory markers in MS patients.
  • To analyze SCFA profiles in relation to disease severity and progression.

Main Methods:

  • A multicentric observational retrospective cross-sectional study including 161 MS patients and 130 HC.
  • Plasma SCFA (acetate, propionate, butyrate) were quantified using liquid chromatography-mass spectrometry.
  • Blood cell subpopulations and cytokine expression were analyzed via flow cytometry.

Main Results:

  • Lower plasma propionate (PA) and PA/acetate (AA) ratios were found in MS patients compared to HC.
  • Reduced PA/AA and butyrate (BA)/AA ratios correlated with higher disability (EDSS) and T2 lesion load in MS patients.
  • SCFA ratios negatively correlated with pro-inflammatory cytokine-producing immune cells (e.g., GM-CSF+, TNF-α+, IFN-γ+ T cells and TNF-α+ B cells).

Conclusions:

  • Plasma PA/AA and BA/AA ratios are unbalanced in MS, potentially promoting disease pathogenesis.
  • These SCFA ratios are significantly associated with EDSS and T2 lesion load, suggesting a link to neurodegenerative processes rather than active disease.
  • Further research into SCFA modulation could offer novel therapeutic strategies for MS.